Supplemental data Experience of dupilumab treatment in inherited epidermolysis bullosa: a short series, Bellon et al

Published: 22 April 2024| Version 1 | DOI: 10.17632/322c766sjw.1
Contributors:
Nathalia Bellon,
,
,
,
,
, Smail Hadj-Rabia,
,

Description

Supplemental data of article "Experience of dupilumab treatment in inherited epidermolysis bullosa: a short series", Bellon et al. * Figure 2s (supplementary data): Heat map analysis of plasmatic cytokines Heat map analysis of plasmatic cytokines ratios calculated as: levels measured after dupilumab treatment/levels measured before dupilumab treatment. Decreased cytokine ratios are represented in blue, and increased cytokine ratios in red. The rows and columns are ordered based on the results of the agglomerative hierarchical clustering, with dendrograms for the patients (7, 3, 10, 4, 1 and 6) and cytokines shown on the vertical and horizontal axes respectively. Heat map was created using Qlucore Omics Explorer software 3.7. * Table 2 supplementary data: Molecular diagnosis * Methods * PGA EB: Physician’s global assessment of Epidermolysis bullosa

Files

Categories

Biologic Agent, Biotherapy, Pediatric Dermatology, Epidermolysis bullosa, Genodermatosis, Pruritus

Licence